Skip to main content

Peer Review reports

From: PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics

Original Submission
15 Jan 2019 Submitted Original manuscript
13 Feb 2019 Author responded Author comments - Xiaoli Sheng
Resubmission - Version 2
13 Feb 2019 Submitted Manuscript version 2
24 Mar 2019 Reviewed Reviewer Report - Xujun He
29 Apr 2019 Reviewed Reviewer Report - Andre F Vieira
27 May 2019 Author responded Author comments - Xiaoli Sheng
Resubmission - Version 3
27 May 2019 Submitted Manuscript version 3
24 Jun 2019 Reviewed Reviewer Report - Xujun He
25 Jun 2019 Reviewed Reviewer Report - Andre F Vieira
11 Jul 2019 Author responded Author comments - Xiaoli Sheng
Resubmission - Version 4
11 Jul 2019 Submitted Manuscript version 4
31 Jul 2019 Author responded Author comments - Xiaoli Sheng
Resubmission - Version 5
31 Jul 2019 Submitted Manuscript version 5
6 Aug 2019 Author responded Author comments - Xiaoli Sheng
Resubmission - Version 6
6 Aug 2019 Submitted Manuscript version 6
Publishing
8 Aug 2019 Editorially accepted
27 Aug 2019 Article published 10.1186/s12885-019-6029-y

You can find further information about peer review here.

Back to article page